Melanoma: Narrowing the sights on an evasive enemy

Richard F. Kefford*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Much of the resistance of melanoma to immunotherapy, radiotherapy and cytotoxic treatment is due to an impressive array of molecular defences that derive ultimately from the essential molecular structure of the melanocyte and its biological requirement for defence against apoptosis. The exploration of melanoma susceptibility genes like CDKN2A, CDK4 and MC1R has highlighted a number of key pathways in melanomagenesis. Others have been revealed by a systematic exploration of somatic chromosomal and genetic abnormalities in naevi and melanomas.

Original languageEnglish
Pages (from-to)110-115
Number of pages6
JournalCancer Forum
Issue number2
Publication statusPublished - May 2006
Externally publishedYes


Dive into the research topics of 'Melanoma: Narrowing the sights on an evasive enemy'. Together they form a unique fingerprint.

Cite this